nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—type 2 diabetes mellitus—metabolic syndrome X	0.933	1	CtDrD
Glimepiride—ABCC8—penis—metabolic syndrome X	0.00621	0.529	CbGeAlD
Glimepiride—Reaction gastrointestinal—Metformin—metabolic syndrome X	0.00362	0.135	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—INS-IGF2—metabolic syndrome X	0.00252	0.0992	CbGpPWpGaD
Glimepiride—Gastrointestinal symptom NOS—Metformin—metabolic syndrome X	0.00205	0.0768	CcSEcCtD
Glimepiride—KCNJ1—kidney—metabolic syndrome X	0.00175	0.149	CbGeAlD
Glimepiride—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—EPHX2—metabolic syndrome X	0.00172	0.0675	CbGpPWpGaD
Glimepiride—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—EPHX2—metabolic syndrome X	0.00154	0.0606	CbGpPWpGaD
Glimepiride—Glyburide—ABCA1—metabolic syndrome X	0.00149	0.471	CrCbGaD
Glimepiride—Accidental injury—Metformin—metabolic syndrome X	0.00137	0.051	CcSEcCtD
Glimepiride—Glipizide—PPARG—metabolic syndrome X	0.00109	0.345	CrCbGaD
Glimepiride—KCNJ11—cardiovascular system—metabolic syndrome X	0.00108	0.0924	CbGeAlD
Glimepiride—KCNJ11—Type II diabetes mellitus—ADIPOQ—metabolic syndrome X	0.00106	0.0418	CbGpPWpGaD
Glimepiride—KCNJ11—Type II diabetes mellitus—SLC2A4—metabolic syndrome X	0.001	0.0395	CbGpPWpGaD
Glimepiride—ABCC8—cardiovascular system—metabolic syndrome X	0.000999	0.0851	CbGeAlD
Glimepiride—ABCC8—kidney—metabolic syndrome X	0.000977	0.0832	CbGeAlD
Glimepiride—Injury—Metformin—metabolic syndrome X	0.000954	0.0357	CcSEcCtD
Glimepiride—Hypoglycaemia—Metformin—metabolic syndrome X	0.000899	0.0336	CcSEcCtD
Glimepiride—Pain in extremity—Metformin—metabolic syndrome X	0.000877	0.0328	CcSEcCtD
Glimepiride—CYP2C9—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.0008	0.0314	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—GCK—metabolic syndrome X	0.000765	0.0301	CbGpPWpGaD
Glimepiride—Abdominal distension—Metformin—metabolic syndrome X	0.000763	0.0285	CcSEcCtD
Glimepiride—Influenza—Metformin—metabolic syndrome X	0.000758	0.0283	CcSEcCtD
Glimepiride—ABCC8—Integration of energy metabolism—MLXIPL—metabolic syndrome X	0.000751	0.0295	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—GCK—metabolic syndrome X	0.000742	0.0292	CbGpPWpGaD
Glimepiride—Angina pectoris—Metformin—metabolic syndrome X	0.000738	0.0276	CcSEcCtD
Glimepiride—Sweating increased—Metformin—metabolic syndrome X	0.000738	0.0276	CcSEcCtD
Glimepiride—KCNJ11—Integration of energy metabolism—MLXIPL—metabolic syndrome X	0.000728	0.0286	CbGpPWpGaD
Glimepiride—Drowsiness—Metformin—metabolic syndrome X	0.000676	0.0253	CcSEcCtD
Glimepiride—Bradycardia—Metformin—metabolic syndrome X	0.000618	0.0231	CcSEcCtD
Glimepiride—Hepatitis—Metformin—metabolic syndrome X	0.000607	0.0227	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—IRS1—metabolic syndrome X	0.00059	0.0232	CbGpPWpGaD
Glimepiride—Malnutrition—Metformin—metabolic syndrome X	0.000528	0.0197	CcSEcCtD
Glimepiride—Erythema—Metformin—metabolic syndrome X	0.000528	0.0197	CcSEcCtD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.000502	0.0197	CbGpPWpGaD
Glimepiride—Vision blurred—Metformin—metabolic syndrome X	0.000498	0.0186	CcSEcCtD
Glimepiride—Tremor—Metformin—metabolic syndrome X	0.000495	0.0185	CcSEcCtD
Glimepiride—Palpitations—Metformin—metabolic syndrome X	0.000467	0.0174	CcSEcCtD
Glimepiride—Loss of consciousness—Metformin—metabolic syndrome X	0.000464	0.0173	CcSEcCtD
Glimepiride—Hypertension—Metformin—metabolic syndrome X	0.000456	0.017	CcSEcCtD
Glimepiride—ABCC8—ABC-family proteins mediated transport—APOA1—metabolic syndrome X	0.000454	0.0179	CbGpPWpGaD
Glimepiride—CYP2C9—cardiovascular system—metabolic syndrome X	0.000446	0.038	CbGeAlD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—NR3C1—metabolic syndrome X	0.00044	0.0173	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NR3C1—metabolic syndrome X	0.000427	0.0168	CbGpPWpGaD
Glimepiride—Shock—Metformin—metabolic syndrome X	0.000424	0.0158	CcSEcCtD
Glimepiride—Thrombocytopenia—Metformin—metabolic syndrome X	0.000422	0.0158	CcSEcCtD
Glimepiride—Hyperhidrosis—Metformin—metabolic syndrome X	0.000417	0.0156	CcSEcCtD
Glimepiride—Anorexia—Metformin—metabolic syndrome X	0.000411	0.0154	CcSEcCtD
Glimepiride—Hypotension—Metformin—metabolic syndrome X	0.000403	0.0151	CcSEcCtD
Glimepiride—Paraesthesia—Metformin—metabolic syndrome X	0.000387	0.0145	CcSEcCtD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—APOA1—metabolic syndrome X	0.000387	0.0152	CbGpPWpGaD
Glimepiride—CYP2C9—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.000386	0.0152	CbGpPWpGaD
Glimepiride—Dyspnoea—Metformin—metabolic syndrome X	0.000384	0.0144	CcSEcCtD
Glimepiride—Somnolence—Metformin—metabolic syndrome X	0.000383	0.0143	CcSEcCtD
Glimepiride—Gliclazide—ALB—metabolic syndrome X	0.000381	0.121	CrCbGaD
Glimepiride—Dyspepsia—Metformin—metabolic syndrome X	0.000379	0.0142	CcSEcCtD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—APOA1—metabolic syndrome X	0.000375	0.0147	CbGpPWpGaD
Glimepiride—Decreased appetite—Metformin—metabolic syndrome X	0.000375	0.014	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000372	0.0139	CcSEcCtD
Glimepiride—Fatigue—Metformin—metabolic syndrome X	0.000372	0.0139	CcSEcCtD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.000367	0.0144	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—EPHX2—metabolic syndrome X	0.000356	0.014	CbGpPWpGaD
Glimepiride—Feeling abnormal—Metformin—metabolic syndrome X	0.000355	0.0133	CcSEcCtD
Glimepiride—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000352	0.0132	CcSEcCtD
Glimepiride—Urticaria—Metformin—metabolic syndrome X	0.000342	0.0128	CcSEcCtD
Glimepiride—Abdominal pain—Metformin—metabolic syndrome X	0.000341	0.0127	CcSEcCtD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000336	0.0132	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—INS—metabolic syndrome X	0.000334	0.0131	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—metabolic syndrome X	0.000324	0.0127	CbGpPWpGaD
Glimepiride—Asthenia—Metformin—metabolic syndrome X	0.000309	0.0116	CcSEcCtD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—metabolic syndrome X	0.000307	0.012	CbGpPWpGaD
Glimepiride—KCNJ11—Type II diabetes mellitus—TNF—metabolic syndrome X	0.000306	0.012	CbGpPWpGaD
Glimepiride—Pruritus—Metformin—metabolic syndrome X	0.000305	0.0114	CcSEcCtD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—metabolic syndrome X	0.000297	0.0117	CbGpPWpGaD
Glimepiride—Diarrhoea—Metformin—metabolic syndrome X	0.000295	0.011	CcSEcCtD
Glimepiride—Dizziness—Metformin—metabolic syndrome X	0.000285	0.0107	CcSEcCtD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.00028	0.011	CbGpPWpGaD
Glimepiride—CYP2C9—liver—metabolic syndrome X	0.000276	0.0235	CbGeAlD
Glimepiride—Vomiting—Metformin—metabolic syndrome X	0.000274	0.0102	CcSEcCtD
Glimepiride—Rash—Metformin—metabolic syndrome X	0.000272	0.0102	CcSEcCtD
Glimepiride—Dermatitis—Metformin—metabolic syndrome X	0.000272	0.0101	CcSEcCtD
Glimepiride—Headache—Metformin—metabolic syndrome X	0.00027	0.0101	CcSEcCtD
Glimepiride—Nausea—Metformin—metabolic syndrome X	0.000256	0.00957	CcSEcCtD
Glimepiride—ABCC8—Regulation of insulin secretion—INS—metabolic syndrome X	0.000214	0.0084	CbGpPWpGaD
Glimepiride—KCNJ11—Regulation of insulin secretion—INS—metabolic syndrome X	0.000207	0.00814	CbGpPWpGaD
Glimepiride—Glyburide—ALB—metabolic syndrome X	0.0002	0.0633	CrCbGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.000193	0.00758	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.000172	0.00677	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—INS—metabolic syndrome X	0.000168	0.0066	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—INS—metabolic syndrome X	0.000163	0.0064	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—FMO3—metabolic syndrome X	0.000149	0.00584	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—FMO3—metabolic syndrome X	0.000147	0.00576	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—GGT1—metabolic syndrome X	0.000137	0.0054	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—metabolic syndrome X	0.000135	0.0053	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.000134	0.00526	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.000131	0.00514	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—metabolic syndrome X	0.000131	0.00514	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.000118	0.00464	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	0.000113	0.00445	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000111	0.00435	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—FMO3—metabolic syndrome X	9.64e-05	0.00379	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—GCK—metabolic syndrome X	9.39e-05	0.00369	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—FMO3—metabolic syndrome X	9.35e-05	0.00367	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—CETP—metabolic syndrome X	9.06e-05	0.00356	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MLXIPL—metabolic syndrome X	8.59e-05	0.00337	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—EPHX2—metabolic syndrome X	8.59e-05	0.00337	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—EPHX2—metabolic syndrome X	8.33e-05	0.00327	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MLXIPL—metabolic syndrome X	8.33e-05	0.00327	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—G6PC2—metabolic syndrome X	8.08e-05	0.00317	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—G6PC2—metabolic syndrome X	7.83e-05	0.00308	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	7.3e-05	0.00287	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—FABP4—metabolic syndrome X	6.87e-05	0.0027	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—FABP4—metabolic syndrome X	6.66e-05	0.00262	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HSD11B1—metabolic syndrome X	6.51e-05	0.00256	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	6.39e-05	0.00251	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HSD11B1—metabolic syndrome X	6.31e-05	0.00248	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—APOB—metabolic syndrome X	6e-05	0.00236	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—G6PD—metabolic syndrome X	5.8e-05	0.00228	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HDAC3—metabolic syndrome X	5.66e-05	0.00222	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—G6PD—metabolic syndrome X	5.63e-05	0.00221	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GCKR—metabolic syndrome X	5.54e-05	0.00217	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LPA—metabolic syndrome X	5.54e-05	0.00217	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HDAC3—metabolic syndrome X	5.49e-05	0.00216	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LPA—metabolic syndrome X	5.37e-05	0.00211	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GCKR—metabolic syndrome X	5.37e-05	0.00211	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLA2G6—metabolic syndrome X	5.36e-05	0.00211	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOA5—metabolic syndrome X	5.31e-05	0.00208	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLA2G6—metabolic syndrome X	5.2e-05	0.00204	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOA5—metabolic syndrome X	5.15e-05	0.00202	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GGT1—metabolic syndrome X	5.11e-05	0.00201	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	5.09e-05	0.002	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	5.06e-05	0.00199	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TRIB3—metabolic syndrome X	4.93e-05	0.00194	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TRIB3—metabolic syndrome X	4.78e-05	0.00188	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	4.75e-05	0.00187	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NAMPT—metabolic syndrome X	4.43e-05	0.00174	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LIPC—metabolic syndrome X	4.4e-05	0.00173	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GCK—metabolic syndrome X	4.4e-05	0.00173	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOC3—metabolic syndrome X	4.37e-05	0.00172	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NAMPT—metabolic syndrome X	4.29e-05	0.00169	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LIPC—metabolic syndrome X	4.26e-05	0.00168	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GCK—metabolic syndrome X	4.26e-05	0.00168	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CETP—metabolic syndrome X	4.24e-05	0.00167	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOC3—metabolic syndrome X	4.24e-05	0.00166	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CETP—metabolic syndrome X	4.11e-05	0.00162	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	4.07e-05	0.0016	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SCARB1—metabolic syndrome X	4.06e-05	0.0016	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SREBF1—metabolic syndrome X	3.94e-05	0.00155	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SCARB1—metabolic syndrome X	3.94e-05	0.00155	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	3.86e-05	0.00152	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMGCR—metabolic syndrome X	3.84e-05	0.00151	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GOT2—metabolic syndrome X	3.84e-05	0.00151	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SREBF1—metabolic syndrome X	3.82e-05	0.0015	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ALB—metabolic syndrome X	3.76e-05	0.00148	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMGCR—metabolic syndrome X	3.72e-05	0.00146	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GOT2—metabolic syndrome X	3.72e-05	0.00146	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCA1—metabolic syndrome X	3.42e-05	0.00134	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC2A4—metabolic syndrome X	3.42e-05	0.00134	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	3.36e-05	0.00132	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCA1—metabolic syndrome X	3.32e-05	0.0013	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC2A4—metabolic syndrome X	3.32e-05	0.0013	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GOT1—metabolic syndrome X	3.31e-05	0.0013	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GGT1—metabolic syndrome X	3.31e-05	0.0013	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	3.28e-05	0.00129	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GGT1—metabolic syndrome X	3.21e-05	0.00126	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GOT1—metabolic syndrome X	3.21e-05	0.00126	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	3.18e-05	0.00125	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	3.14e-05	0.00124	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	2.92e-05	0.00115	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOB—metabolic syndrome X	2.81e-05	0.0011	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLA2G4A—metabolic syndrome X	2.73e-05	0.00107	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOB—metabolic syndrome X	2.73e-05	0.00107	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LPL—metabolic syndrome X	2.68e-05	0.00105	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLA2G4A—metabolic syndrome X	2.65e-05	0.00104	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	2.61e-05	0.00102	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LPL—metabolic syndrome X	2.6e-05	0.00102	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	2.59e-05	0.00102	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CD36—metabolic syndrome X	2.55e-05	0.001	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—FMO3—metabolic syndrome X	2.54e-05	0.000999	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	2.51e-05	0.000988	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CD36—metabolic syndrome X	2.47e-05	0.000971	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	2.41e-05	0.000946	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARA—metabolic syndrome X	2.37e-05	0.000931	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	2.34e-05	0.000918	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARA—metabolic syndrome X	2.3e-05	0.000903	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AGT—metabolic syndrome X	2.3e-05	0.000902	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	2.27e-05	0.000893	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—EPHX2—metabolic syndrome X	2.27e-05	0.000891	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MLXIPL—metabolic syndrome X	2.27e-05	0.000891	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOE—metabolic syndrome X	2.25e-05	0.000884	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AGT—metabolic syndrome X	2.23e-05	0.000875	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOA1—metabolic syndrome X	2.22e-05	0.000874	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOE—metabolic syndrome X	2.18e-05	0.000857	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOA1—metabolic syndrome X	2.16e-05	0.000847	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—G6PC2—metabolic syndrome X	2.13e-05	0.000837	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	2.03e-05	0.000796	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	1.96e-05	0.000771	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARG—metabolic syndrome X	1.96e-05	0.00077	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—INS—metabolic syndrome X	1.92e-05	0.000755	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARG—metabolic syndrome X	1.9e-05	0.000746	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—INS—metabolic syndrome X	1.86e-05	0.000732	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—FABP4—metabolic syndrome X	1.81e-05	0.000712	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALB—metabolic syndrome X	1.76e-05	0.000692	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD11B1—metabolic syndrome X	1.72e-05	0.000675	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALB—metabolic syndrome X	1.71e-05	0.000671	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NOS3—metabolic syndrome X	1.69e-05	0.000662	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.67e-05	0.000654	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NOS3—metabolic syndrome X	1.63e-05	0.000642	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.62e-05	0.000637	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.59e-05	0.000625	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS2—metabolic syndrome X	1.54e-05	0.000606	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—G6PD—metabolic syndrome X	1.53e-05	0.000602	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.51e-05	0.000594	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	1.49e-05	0.000587	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS2—metabolic syndrome X	1.49e-05	0.000587	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GCKR—metabolic syndrome X	1.46e-05	0.000574	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LPA—metabolic syndrome X	1.46e-05	0.000574	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	1.41e-05	0.000556	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.4e-05	0.000552	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOA5—metabolic syndrome X	1.4e-05	0.00055	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.36e-05	0.000534	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.33e-05	0.000524	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.32e-05	0.000518	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	1.3e-05	0.000512	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	1.17e-05	0.000459	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.16e-05	0.000456	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LIPC—metabolic syndrome X	1.16e-05	0.000456	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GCK—metabolic syndrome X	1.16e-05	0.000456	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOC3—metabolic syndrome X	1.15e-05	0.000453	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CETP—metabolic syndrome X	1.12e-05	0.00044	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	1.07e-05	0.000421	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.04e-05	0.00041	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	1.04e-05	0.000409	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GOT2—metabolic syndrome X	1.01e-05	0.000398	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	1.01e-05	0.000398	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	9.13e-06	0.000359	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	9.03e-06	0.000355	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	9.03e-06	0.000355	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GOT1—metabolic syndrome X	8.74e-06	0.000343	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GGT1—metabolic syndrome X	8.74e-06	0.000343	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKT1—metabolic syndrome X	7.75e-06	0.000304	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKT1—metabolic syndrome X	7.51e-06	0.000295	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOB—metabolic syndrome X	7.42e-06	0.000291	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	7.22e-06	0.000283	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LPL—metabolic syndrome X	7.08e-06	0.000278	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CD36—metabolic syndrome X	6.73e-06	0.000264	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARA—metabolic syndrome X	6.26e-06	0.000246	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AGT—metabolic syndrome X	6.06e-06	0.000238	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOE—metabolic syndrome X	5.94e-06	0.000233	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOA1—metabolic syndrome X	5.87e-06	0.000231	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARG—metabolic syndrome X	5.17e-06	0.000203	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—INS—metabolic syndrome X	5.07e-06	0.000199	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALB—metabolic syndrome X	4.65e-06	0.000183	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NOS3—metabolic syndrome X	4.45e-06	0.000175	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	4.07e-06	0.00016	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKT1—metabolic syndrome X	2.04e-06	8.03e-05	CbGpPWpGaD
